Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
0.8198
+0.0498 (6.47%)
At close: Jan 9, 2026, 4:00 PM EST
0.8368
+0.0170 (2.07%)
After-hours: Jan 9, 2026, 7:44 PM EST
Decoy Therapeutics Employees
Decoy Therapeutics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,502,379
Market Cap
5.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - |
| Dec 31, 2023 | 2 | -10 | -83.33% |
| Dec 31, 2022 | 12 | -4 | -25.00% |
| Dec 31, 2021 | 16 | 7 | 77.78% |
| Dec 31, 2020 | 9 | 1 | 12.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Amazon.com | 1,578,000 |
| Berkshire Hathaway | 392,400 |
| Microsoft | 228,000 |
| Alphabet | 190,167 |
| Apple | 166,000 |
| Tesla | 125,665 |
| Taiwan Semiconductor Manufacturing Company | 83,825 |
| Meta Platforms | 78,450 |
DCOY News
- 2 days ago - Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics - GlobeNewsWire
- 21 days ago - Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting - GlobeNewsWire
- 22 days ago - Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform - GlobeNewsWire
- 5 weeks ago - Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study - GlobeNewsWire
- 7 weeks ago - Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” - GlobeNewsWire
- 2 months ago - Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger - GlobeNewsWire
- 2 months ago - Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering - PRNewsWire
- 3 months ago - Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements - GlobeNewsWire